CWG
ARCT icon

C WorldWide Group’s Arcturus Therapeutics ARCT Stock Holding History

C WorldWide Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,514
Closed -$380K – 130
2014
Q3 		$380K Buy
+3,514
New +$458K 0.01% 98

Other funds holding ARCT

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

C WorldWide Group's ARCT Position: Q4 2014 in Review

C WorldWide Group sold out of Arcturus Therapeutics (ARCT) in Q4 2014, closing a stake of 3,514 shares — an estimated $380K sold.

C WorldWide Group first reported a position in ARCT in Q3 2014 and held it in 1 quarter. The position peaked at $380K in Q3 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q4 2014.

  • C WorldWide Group reported no remaining Arcturus Therapeutics position as of Q4 2014 after selling out during the quarter.
  • C WorldWide Group sold 3,514 Arcturus Therapeutics shares in Q4 2014, an estimated $380K.
  • C WorldWide Group first reported a position in Arcturus Therapeutics in Q3 2014 and held it in 1 quarter.
  • C WorldWide Group's Arcturus Therapeutics position peaked at $380K in Q3 2014.
  • 28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2014.

Based on C WorldWide Group's 13F filing for Q4 2014, filed 11 Feb 2015.